Docket-Specific Pre-Screen
What we confirm before every Suboxone lead is delivered
- Suboxone film (buprenorphine/naloxone sublingual film) use confirmed — NOT Suboxone tablets.
- Duration of use confirmed — minimum 6 months of Suboxone film.
- Dental injuries documented — severe tooth decay, tooth loss, cracked teeth, or dental erosion.
- Dental treatment documentation referenced — dentist visits, procedures, restorations, or extractions.
- Correlation documented — dental problems developed or worsened during the Suboxone film use period.
- Indivior (manufacturer) dental injury knowledge post-dates confirmed use period.
- SOL analyzed under the discovery rule per diagnosis state.
- Not currently represented — confirmed before the lead leaves our system.
SOL Note
Suboxone dental injury SOL follows the discovery rule in most jurisdictions — it runs from the date the claimant knew or should have known the dental damage was linked to Suboxone. FDA issued a safety warning in 2022, which is a reference point for many states.
The Market
The Suboxone market
Suboxone sublingual film (not tablets) is linked to severe dental injuries — acidic degradation of tooth enamel and cementum leading to tooth decay, tooth loss, and extensive restorative dentistry. The FDA issued a safety warning in January 2022 specifically about dental problems associated with buprenorphine-containing medicines dissolved in the mouth.
The litigation targets Indivior, the manufacturer of Suboxone film, on failure-to-warn theories. The claimant population is recovering opioid users who were prescribed Suboxone film as medication-assisted treatment and developed significant dental damage. Case volume is highest in states with large opioid treatment populations: West Virginia, Kentucky, Ohio, Pennsylvania, Tennessee, and Virginia.
Why Suboxone leads need specialist qualification: Suboxone tablets are not part of this docket — only the sublingual film formulation is because the film's dissolution in the mouth is the causation theory. Our pre-screen specifically confirms film (not tablet) use before delivery, which is the single most important filter on this docket.
Docket Pipeline
How Suboxone leads are qualified
Targeted Acquisition
Only people who matched your exact criteria submitted a form.
Form Pre-Screen
SOL, liability, insurance, and intent — all confirmed before delivery.
Suboxone pre-screen confirms film formulation (not tablets), 6+ months use, and documented dental damage.
OTP Phone Verification
The number is real. We proved it before you see it.
Exclusive Delivery
Your CRM. One firm. In under 15 seconds.
Pricing is per qualified lead — never a retainer, never a setup fee, never a monthly commitment. Calculate your all-in cost per signed retainer before you book the call.
Delivery Standards
How every lead arrives and what stands behind it
Every lead passes through four verification steps before delivery. Targeted acquisition drives intake traffic only from people who match your stated criteria. The form pre-screen documents SOL, liability, injury severity, and representation status. OTP phone verification confirms the number is real, active, and in possession of the claimant — not Google Voice, not a disconnected line, not a wrong number. Exclusive delivery places the lead into your CRM inside 15 seconds, locked to your firm ID with a permanent delivery timestamp.
Exclusivity is contractual, not verbal. Your client agreement contains a binding exclusivity term — every lead is sold to exactly one firm and there is no operational path for us to re-deliver it. TrustedForm certificates and Jornaya lead IDs travel with every lead as an independent consent audit trail, timestamped outside our own delivery system. The 48-hour credit exchange is written into your agreement as a contract term, not a return policy: expired SOL at delivery, liability that clearly does not hold based on pre-screen facts, case type mismatch, or represented-at-delivery all qualify without additional documentation. Your intake team’s assessment is sufficient.
Coverage runs in 38 states. Pricing is per qualified lead — no retainer, no setup fee, no monthly commitment. Volume can be paused or reduced with 30 days notice without penalty. Auto-connect puts your intake team on the phone with the claimant within 60 seconds of delivery, which is the single largest lever on contact-to-signed-retainer conversion in every vendor benchmark we have run. Firms routinely report 18–23% close rates on identical leads simply by moving first-call contact from 5 minutes to 60 seconds.
Read the full pipeline breakdown for operational detail on each verification step, or run your numbers with the cost-per-retainer calculator before booking a call.
Frequently Asked Questions
- Suboxone leads are priced at $500 per qualified lead. No retainer. No setup fee. Volume tiers activate on commitment.
Related dockets
The Arrangement
No retainer. No setup fee. No monthly commitment.
Start receiving verified leads in 5–7 days. One firm per case. Every lead OTP-verified. Credit exchange written into your client agreement.